Credit Suisse’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-49,780
| Closed | -$251K | – | 3063 |
|
|
2023
Q3 | $251K | Sell |
49,780
-1,561
| -3% | -$10.8K | ﹤0.01% | 2980 |
|
|
2023
Q2 | $469K | Buy |
51,341
+21,178
| +70% | +$197K | ﹤0.01% | 2814 |
|
|
2023
Q1 | $285K | Buy |
30,163
+10
| +0% | +$91 | ﹤0.01% | 3010 |
|
|
2022
Q4 | $301K | Buy |
30,153
+29,926
| +13,183% | +$332K | ﹤0.01% | 3037 |
|
|
2022
Q3 | $3K | Buy |
+227
| New | +$2.27K | ﹤0.01% | 3664 |
|
|
2022
Q2 | – | Sell |
-37,890
| Closed | -$301K | – | 3926 |
|
|
2022
Q1 | $301K | Buy |
37,890
+2,152
| +6% | +$18.6K | ﹤0.01% | 3228 |
|
|
2021
Q4 | $335K | Sell |
35,738
-2,801
| -7% | -$33.6K | ﹤0.01% | 4074 |
|
|
2021
Q3 | $609K | Buy |
38,539
+2,791
| +8% | +$50.1K | ﹤0.01% | 3683 |
|
|
2021
Q2 | $772K | Buy |
35,748
+9,361
| +35% | +$189K | ﹤0.01% | 3570 |
|
|
2021
Q1 | $534K | Sell |
26,387
-20,458
| -44% | -$404K | ﹤0.01% | 3727 |
|
|
2020
Q4 | $840K | Buy |
46,845
+17,501
| +60% | +$257K | ﹤0.01% | 3450 |
|
|
2020
Q3 | $341K | Sell |
29,344
-5,576
| -16% | -$64.8K | ﹤0.01% | 3583 |
|
|
2020
Q2 | $323K | Buy |
34,920
+10,951
| +46% | +$98.1K | ﹤0.01% | 3542 |
|
|
2020
Q1 | $250K | Buy |
23,969
+222
| +0.9% | +$2.83K | ﹤0.01% | 3531 |
|
|
2019
Q4 | $425K | Sell |
23,747
-2,175
| -8% | -$32.1K | ﹤0.01% | 3655 |
|
|
2019
Q3 | $322K | Sell |
25,922
-5,745
| -18% | -$94.6K | ﹤0.01% | 3665 |
|
|
2019
Q2 | $626K | Buy |
31,667
+1,048
| +3% | +$22.4K | ﹤0.01% | 3269 |
|
|
2019
Q1 | $644K | Buy |
30,619
+2,309
| +8% | +$42.2K | ﹤0.01% | 3199 |
|
|
2018
Q4 | $579K | Sell |
28,310
-46,804
| -62% | -$1.46M | ﹤0.01% | 3168 |
|
|
2018
Q3 | $2.77M | Sell |
75,114
-5,415
| -7% | -$236K | ﹤0.01% | 2113 |
|
|
2018
Q2 | $4.05M | Buy |
80,529
+8,169
| +11% | +$360K | ﹤0.01% | 1892 |
|
|
2018
Q1 | $2.64M | Buy |
72,360
+37,008
| +105% | +$1.14M | ﹤0.01% | 2198 |
|
|
2017
Q4 | $1M | Buy |
35,352
+5,890
| +20% | +$139K | ﹤0.01% | 2993 |
|
|
2017
Q3 | $570K | Buy |
+29,462
| New | +$495K | ﹤0.01% | 3469 |
|
|
2016
Q4 | – | Sell |
-10,765
| Closed | -$97K | – | 4088 |
|
|
2016
Q3 | $97K | Sell |
10,765
-3,179
| -23% | -$25.8K | ﹤0.01% | 3936 |
|
|
2016
Q2 | $96K | Sell |
13,944
-25,493
| -65% | -$144K | ﹤0.01% | 4066 |
|
|
2016
Q1 | $212K | Buy |
+39,437
| New | +$200K | ﹤0.01% | 3660 |
|
Other funds holding AXGN
ACH
SCM
DCM
PA
Credit Suisse's AXGN Position: Q4 2023 in Review
Credit Suisse sold out of Axogen (AXGN) in Q4 2023, closing a stake of 49,780 shares — an estimated $251K sold.
Credit Suisse first reported a position in AXGN in Q1 2016 and held it in 27 quarters. The position peaked at $4.05M in Q2 2018. 124 funds tracked by Wall St. Rank hold AXGN as of Q4 2023.
- Credit Suisse reported no remaining Axogen position as of Q4 2023 after selling out during the quarter.
- Credit Suisse sold 49,780 Axogen shares in Q4 2023, an estimated $251K.
- Credit Suisse first reported a position in Axogen in Q1 2016 and held it in 27 quarters.
- Credit Suisse's Axogen position peaked at $4.05M in Q2 2018.
- 124 funds tracked by Wall St. Rank held Axogen as of Q4 2023.
Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.